A Professional Guide to Rejuran Skinbooster 3+3 Wholesale Price & Clinic Margins

Rejuran Skinbooster 3+3 is a biostimulator product developed by Pharma Research in South Korea. It is supplied for professional use in a package containing three syringes of a c-PDRN, HA, and amino acid solution, alongside three vials of an amino acid solution. This dual-component format is intended for combination prior to application.

As a polynucleotide (PN) based product, it is categorized within the broader class of skinboosters and biostimulators. Professionals sourcing these products for their clinics should be familiar with their distinct handling and preparation requirements compared to standard hyaluronic acid fillers. The specific composition positions it among a growing category of Korean-origin injectables focused on improving skin condition. For a wider view of this category, practitioners can review the complete Skinbooster / biostimulator catalog.

The baseline wholesale price for a single unit of Rejuran Skinbooster 3+3 serves as the starting point for all profitability calculations. As an illustrative example, a single-unit cost might be approximately $197.0. This figure represents the direct cost of goods sold (COGS) for the product itself, before accounting for shipping, import duties, or other logistical expenses that may apply depending on the destination market.

This single-unit price is most relevant for clinics placing smaller, ad-hoc orders or those new to the product line. However, to accurately assess its financial viability, this cost must be evaluated in the context of volume-based discounts and the final retail price charged to patients.

To establish a profitable retail price for a Rejuran Skinbooster treatment, clinic managers must account for more than just the product's wholesale cost. The final price presented to a patient is a function of several factors:

• Direct Product Cost: The per-unit wholesale price paid for the Rejuran Skinbooster 3+3 kit.
• Consumables: The cost of needles, cannulas, antiseptics, and other single-use items required for the procedure.
• Practitioner's Fee: Compensation for the skilled professional administering the treatment. This varies based on experience, geography, and clinic positioning.
• Clinic Overhead: A portion of fixed costs such as rent, utilities, insurance, and administrative salaries allocated to the treatment time.
• Profit Margin: The percentage markup the clinic aims to achieve on the service.

For example, if the wholesale unit cost is $197 and the combined cost of consumables, practitioner time, and overhead for the procedure is estimated at $150, the total treatment cost for the clinic is $347. Applying a desired markup (e.g., 100%) would suggest a retail price of approximately $694. This model must be adapted to local market conditions and competitive pricing.

Sourcing injectables through a tiered pricing structure offers a direct path to improved margins. Distributors typically provide discounts based on the quantity ordered in a single transaction. By purchasing in larger volumes, clinics can significantly lower their per-unit cost, which translates directly into higher profit per treatment, assuming the retail price remains constant.

Consider the following illustrative volume discount structure:

Using the $197 baseline, a clinic ordering 51+ units would pay approximately $181.24 per unit (a saving of $15.76). While this may seem modest, across dozens of treatments, these savings accumulate and substantially enhance the service's overall profitability. This economic principle is central to effective inventory management in aesthetics, a concept also explored in our Juvelook 50mg: A Professional Wholesale Price & Margin Analy guide.

Rejuran's polynucleotide-based formulation places it in the biostimulator category, alongside products that aim to work with the body's own processes. While its mechanism is distinct, it is often considered by clinics offering services like poly-L-lactic acid (PLLA) treatments, such as Sculptra (2 vials), or calcium hydroxylapatite (CaHA) fillers. Each product has a different composition, protocol, and pricing structure that must be evaluated.

The rise of Korean injectables has introduced a wide array of options for clinics. Products like AMI Eyes, which also uses polynucleotides, offer alternatives that may appeal to different clinic demographics or price points. Understanding these nuances is key, as explored in our journal post, Analyzing Korean HA Filler Market Trends for Professional So.